Not Tagged
astrazeneca,bayer
['bayer', 'astrazeneca']
i am not just here tweeting my musings i'm also reporting! my latest this morning is on astrazeneca's bispecific. early data shows promise, but the company had to significantly shrink the dose mid-trial to lessen the side effects. #esmo22 
staff writer @FierceBiotech covering new drug development | ?? mbayer@questex.com or DM for Signal | past: @CBSNews | he/him